At today’s AGM, the company reiterated its confidence in meeting FY 2023 market expectations, despite a previously identified H2 bias (67% of sales), which should benefit from a c.£0.6m order from China, stronger-than-expected growth from CNS and delayed customer orders for FoodPrint, following re-registrations in May 2022. We leave forecasts unchanged and reiterate our target price of 12p – the stock is currently trading at forecast year-end cash and should benefit from confirmation that the co ....
26 Oct 2022
Omega Diagnostics - AGM statement – FY 2023 expectations unchanged
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Omega Diagnostics - AGM statement – FY 2023 expectations unchanged
Cambridge Nutritional Sciences PLC (CNSL:LON) | 3.8 0 (-3.8%) | Mkt Cap: 9.16m
- Published:
26 Oct 2022 -
Author:
Mark Brewer | Cavendish Research -
Pages:
4
At today’s AGM, the company reiterated its confidence in meeting FY 2023 market expectations, despite a previously identified H2 bias (67% of sales), which should benefit from a c.£0.6m order from China, stronger-than-expected growth from CNS and delayed customer orders for FoodPrint, following re-registrations in May 2022. We leave forecasts unchanged and reiterate our target price of 12p – the stock is currently trading at forecast year-end cash and should benefit from confirmation that the co ....